Adenoid cystic carcinoma of head and neck: A single institutional analysis of 66 patients treated with multi-modality approach
Background: Adenoid cystic carcinoma (ACC) accounts for 1% of all head and neck (HN) cancers.Materials and Methods: Demographic, clinical, treatment, and survival details of 66 patients were collected (1995-2011) and analyzed.Disease-free survival (DFS) was estimated by Kaplan-Meier method.Results: Primary disease sites were sinonasal (n = 27), sal